中文名称 | 奥当卡替 |
---|---|
英文名称 | Odanacatib (Synonyms: MK-0822) |
CAS号 | 603139-19-1 |
分子式 | C25H27F4N3O3S |
分子量 | 525.56 |
外观 | White to brown powder |
储存条件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Odanacatib (also known as MK-0822) is a potent, neutral, and selective inhibitor of human/rabbit cathepsin K that may be applied to the management of bone metastases and osteoporosis. With IC50s of 0.2 nM/1 nM, it inhibits cathepsin K (human/rabbit) and shows good selectivity against off-target cathepsins B, L, and S. Odanacatib binds to cathepsin K specifically and inhibits its activity. This may reduce bone resorption, improve bone mineral density, and reverse osteoporotic changes. Approximately 16,000 postmenopausal osteoporosis patients are participating in a phase III trial to assess the potential of odanacatib to reduce fracture risk.
Keywords: buy Odanacatib | Odanacatib supplier | purchase Odanacatib | Odanacatib cost | Odanacatib manufacturer | order Odanacatib | Odanacatib distributor
© 2020-2024 凯立德生物医药技术(上海)有限公司 版权所有
沪ICP备15046197号-3
沪公网安备31011502007856号
Designed by Kuanersoft